Literature DB >> 17978660

Aggrecanases and aggrecanase-generated fragments in the human intervertebral disc at early and advanced stages of disc degeneration.

Kalpa P Patel1, John D Sandy, Koji Akeda, Kei Miyamoto, Takehide Chujo, Howard S An, Koichi Masuda.   

Abstract

STUDY
DESIGN: A comparative study of aggrecanases and aggrecan fragmentation profile in the human intervertebral disc at early and advanced stages of disc degeneration.
OBJECTIVE: To determine differences in the content of the aggrecanases and the profile of aggrecan fragmentation in early and advanced stages of disc degeneration using cadaveric human intervertebral discs. SUMMARY OF BACKGROUND DATA: Aggrecanases and aggrecanase-generated aggrecan fragments have been found in human degenerated discs. However, the association between the grade of disc degeneration and the content of the aggrecanases and the profile of aggrecan fragments has not been well studied.
METHODS: A total of 108 cadaveric donor spines were assessed by MRI T2 imaging and graded based on the Thompson scale. Twelve donor spines (average age, 63 years), each specifically exhibiting 2 different stages (Grade 2 and Grade 4) of disc degeneration at different disc levels, were included in this study. After harvesting the preselected discs, tissue samples were obtained from the center of the nucleus pulposus (NP) and the middle zone of the anulus fibrosus (AF). The amount of the aggrecanases, specifically ADAMTS-4 and ADAMTS-5, and the pattern of aggrecan fragmentation in the isolated tissues were assessed by western blot using specific antibodies.
RESULTS: In both NP and the AF tissues, the amount of ADAMTS-4 detected was higher in disc tissues with a higher level of degeneration (Grade 4) than in Grade 2 disc tissues with a lower level of degeneration. However, the amount of ADAMTS-5 detected did not differ between the 2 disc tissue grades. The aggrecan fragmentation analysis of these samples demonstrated the presence of aggrecanase-mediated fragmentation in both groups; however, there was no apparent difference in the aggrecan fragmentation profile between discs at early and advanced stages of disc degeneration.
CONCLUSION: Aggrecanases are involved in aggrecanolysis at both the early and advanced stages of disc degeneration. The aggrecan fragmentation profile analysis demonstrates the involvement of aggrecanases, as well as that of matrix metalloproteinases and/or cathepsins, during disc degeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978660     DOI: 10.1097/BRS.0b013e318158cb85

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  47 in total

1.  Transcript levels of major MMPs and ADAMTS-4 in relation to the clinicopathological profile of patients with lumbar disc herniation.

Authors:  Alexandros Tsarouhas; Giannoula Soufla; Pavlos Katonis; Dritan Pasku; Antonis Vakis; Demetrios A Spandidos
Journal:  Eur Spine J       Date:  2010-09-22       Impact factor: 3.134

2.  Association of vitamin D receptor gene polymorphisms with disc degeneration.

Authors:  Adam Biczo; Julia Szita; Iain McCall; Peter Pal Varga; Aron Lazary
Journal:  Eur Spine J       Date:  2019-11-25       Impact factor: 3.134

3.  Spine degeneration in a murine model of chronic human tobacco smokers.

Authors:  D Wang; L A Nasto; P Roughley; A S Leme; A M Houghton; A Usas; G Sowa; J Lee; L Niedernhofer; S Shapiro; J Kang; N Vo
Journal:  Osteoarthritis Cartilage       Date:  2012-04-21       Impact factor: 6.576

Review 4.  Role of cytokines in intervertebral disc degeneration: pain and disc content.

Authors:  Makarand V Risbud; Irving M Shapiro
Journal:  Nat Rev Rheumatol       Date:  2013-10-29       Impact factor: 20.543

5.  Interference in the endplate nutritional pathway causes intervertebral disc degeneration in an immature porcine model.

Authors:  Ran Kang; Haisheng Li; Steffen Ringgaard; Kresten Rickers; Haolin Sun; Muwan Chen; Lin Xie; Cody Bünger
Journal:  Int Orthop       Date:  2014-03-22       Impact factor: 3.075

Review 6.  Reconstruction of an in vitro niche for the transition from intervertebral disc development to nucleus pulposus regeneration.

Authors:  Mark Shoukry; Jingting Li; Ming Pei
Journal:  Stem Cells Dev       Date:  2013-02-15       Impact factor: 3.272

Review 7.  Emerging technologies for molecular therapy for intervertebral disk degeneration.

Authors:  Won C Bae; Koichi Masuda
Journal:  Orthop Clin North Am       Date:  2011-10       Impact factor: 2.472

8.  Adamts5 deletion blocks murine dermal repair through CD44-mediated aggrecan accumulation and modulation of transforming growth factor β1 (TGFβ1) signaling.

Authors:  Jennifer Velasco; Jun Li; Luisa DiPietro; Mary Ann Stepp; John D Sandy; Anna Plaas
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

Review 9.  Suppression of aggrecanase: a novel protective mechanism of dehydroepiandrosterone in osteoarthritis?

Authors:  Kai Huang; Li-dong Wu
Journal:  Mol Biol Rep       Date:  2009-03-10       Impact factor: 2.316

10.  Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc.

Authors:  Stephen M Richardson; Paul Doyle; Ben M Minogue; Kanna Gnanalingham; Judith A Hoyland
Journal:  Arthritis Res Ther       Date:  2009-08-20       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.